150 related articles for article (PubMed ID: 37334762)
21. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
22. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
23. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
24. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
25. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
26. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
Lu R; Yang Z; Xu G; Yu S
Biomed Pharmacother; 2018 Sep; 105():633-644. PubMed ID: 29898430
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-κB signaling.
Gu ZL; Huang J; Zhen LL
Kaohsiung J Med Sci; 2020 Jun; 36(6):399-404. PubMed ID: 32003539
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
Yang X; Feng KX; Li H; Wang L; Xia H
Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
30. m
Zhao Q; Zhao Y; Hu W; Zhang Y; Wu X; Lu J; Li M; Li W; Wu W; Wang J; Du F; Ji H; Yang X; Xu Z; Wan L; Wen Q; Li X; Cho CH; Zou C; Shen J; Xiao Z
Theranostics; 2020; 10(21):9528-9543. PubMed ID: 32863943
[No Abstract] [Full Text] [Related]
31. CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway.
Luan Y; Zhang W; Xie J; Mao J
Clin Transl Oncol; 2021 Feb; 23(2):222-228. PubMed ID: 32594303
[TBL] [Abstract][Full Text] [Related]
32. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
33. Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway.
Zhang W; Xue F; Xie S; Chen C; Li J; Zhu X
Mol Cell Biochem; 2021 Jan; 476(1):45-55. PubMed ID: 32833118
[TBL] [Abstract][Full Text] [Related]
34. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
35. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
36. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
Du J; Gong A; Zhao X; Wang G
Dig Dis Sci; 2022 Apr; 67(4):1260-1270. PubMed ID: 33811565
[TBL] [Abstract][Full Text] [Related]
37. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway.
Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
[TBL] [Abstract][Full Text] [Related]
38. α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway.
Pei XD; Yao HL; Shen LQ; Yang Y; Lu L; Xiao JS; Wang XY; He ZL; Jiang LH
Eur J Pharmacol; 2020 Sep; 883():173355. PubMed ID: 32687921
[TBL] [Abstract][Full Text] [Related]
39. OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer.
Wan Q; Chen Q; Cai D; Zhao Y; Wu X
Cell Transplant; 2020; 29():963689720931433. PubMed ID: 32830515
[TBL] [Abstract][Full Text] [Related]
40. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
